Compile Data Set for Download or QSAR
Report error Found 171 Enz. Inhib. hit(s) with all data for entry = 132
TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183615(US9670142, A79 fluoro-4'-trifluoromethoxy-biph...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183609(US9670142, A78 biphenyl-4,4'-dicarboxylic acid...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183604(US9670142, A77 cyano-2'-fluoro-biphenyl-4-carb...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183588(US9670142, A76 4-(1H-benzimidazol-5-yl)-N-methyl-N...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183578(US9670142, A75 N-methyl-4-(1-methyl-1H-indazol-5-y...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183576(US9670142, A74 N-methyl-4-(1-methyl-1H-indazol-6-y...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183575(US9670142, A73 4'-methyl-biphenyl-4-carboxylic...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183572(US9670142, A72 N-methyl-N-((1R,3S)-3-propionylamin...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183634(US9670142, A87 4-(2,3-dihydro-benzo[1,4]dioxin-6-y...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183633(US9670142, A86 4'-chloro-3'-fluoro-bipheny...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183632(US9670142, A85 4'-difluoromethoxy-biphenyl-4-c...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183628(US9670142, A84 4-(1H-indazol-5-yl)-N-methyl-N-((1R...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183626(US9670142, A83 2',4'-difluoro-biphenyl-4-c...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183625(US9670142, A82 4'-methoxy-biphenyl-4-carboxyli...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183624(US9670142, A81 4'-(2H-pyrazol-3-yl)-biphenyl-4...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183616(US9670142, A80 N-methyl-4-(1-methyl-1H-indol-5-yl)...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184410(US9670142, A95 4-(1H-indol-5-yl)-N-methyl-N-((1R,3...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184409(US9670142, A94 N-methyl-4-(2-oxo-2,3-dihydro-1H-in...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184408(US9670142, A93 N-methyl-4-(2-oxo-2,3-dihydro-1H-be...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184407(US9670142, A92 4'-chloro-2'-fluoro-bipheny...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184406(US9670142, A91 4-(1H-benzotriazol-5-yl)-N-methyl-N...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184405(US9670142, A90 2',4'-dimethyl-biphenyl-4-c...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183639(US9670142, A88 2',4'-dimethoxy-biphenyl-4-...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184478(US9670142, A102 N-methyl-4-(6-methyl-1H-indazol-5-...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184418(US9670142, A101 4-(1H-indol-5-yl)-3,N-dimethyl-N-(...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184416(US9670142, A100 N-methyl-4-(3-methyl-1H-indazol-5-...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184415(US9670142, A99a 4-(3-cyano-1H-indol-5-yl)-N-methyl...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184414(US9670142, A99 2'-fluoro-4'-methoxy-biphen...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183615(US9670142, A79 fluoro-4'-trifluoromethoxy-biph...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184412(US9670142, A97 2-fluoro-4'-[methyl-((1R,3S)-3-...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184540(US9670142, A110 5-(1-methyl-1H-indol-5-yl)-pyridin...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184539(US9670142, A109 5-(1H-indol-5-yl)-pyridine-2-carbo...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184538(US9670142, A108 3-fluoro-N-methyl-4-(1-methyl-1H-i...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184537(US9670142, A107 N-methyl-4-(7-methyl-1H-indazol-5-...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184499(US9670142, A106 2-fluoro-4-(1H-indol-5-yl)-N-methy...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184493(US9670142, A105 5-(3-methyl-1H-indazol-5-yl)-pyrid...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184492(US9670142, A104 5-(7-methyl-1H-indazol-5-yl)-pyrid...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM185360(US9670142, A118 6-(1-methyl-1H-indol-5-yl)-pyridaz...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM185359(US9670142, A117 6-(1H-indol-5-yl)-N-methyl-N-((1R,...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184615(US9670142, A116 4-(4-fluoro-1H-indol-5-yl)-N-methy...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184585(US9670142, A115 N-methyl-4-(3-methyl-1H-indol-5-yl...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184573(US9670142, A114 3,N-dimethyl-4-(1-methyl-1H-indol-...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184550(US9670142, A113 6-(1H-indol-5-yl)-pyridazine-3-car...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184547(US9670142, A112 3-fluoro-4-(1H-indol-5-yl)-N-methy...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM184541(US9670142, A111 2-fluoro-N-methyl-4-(1-methyl-1H-i...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM185540(US9670142, A126 N-methyl-4-(4-methyl-1H-indazol-5-...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM185537(US9670142, A125 5-(1-methyl-1H-indol-5-yl)-pyrazin...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM185533(US9670142, A124 3,N-dimethyl-4-(4-methyl-1H-indazo...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM185520(US9670142, A123 N-methyl-4-(1-methyl-1H-benzimidaz...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM185518(US9670142, A122 4-(6-fluoro-1H-indol-5-yl)-N-methy...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
US Patent

Displayed 1 to 50 (of 171 total ) | Next | Last >>
Jump to: